Хроническая обструктивная болезнь легких и пневмосклероз – еще один фенотип
Аннотация
Хроническая обструктивная болезнь легких и пневмосклероз – еще один фенотип.
Об авторе
В. Н. Абросимов
ГБОУ ВПО РязГМУ Минздравсоцразвития России
Россия
Россия
д. м. н., проф., зав. кафедрой терапии ФПДО с курсом семейной медицины
390026, Рязань, ул. Высоковольтная, 9. Тел. / факс: (4912) 96-27-93.
Список литературы
1. Путов Н.В., Федосеев Г.Б. (ред.). Руководство по пульмонологии. Л.: Медицина; 1984.
2. Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. М.: Атмосфера; 2008.
3. Fishman A.P. One hundred years of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 171 (5): 941–948.
4. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop Report. Last updated. 2011.
5. Filleu G.F., Beckwitt H.J., Reeves J.T., Mitchell R.S. Oxygen transport in two clinical types. Am. J. Med. 1968; 44: 26–28.
6. Aldrich T.K. Pink puffers vs blue bloaters in asthma too? Chest 2002; 121: 313–315.
7. Chung K. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 2008; 31: 1334–1356.
8. Fingleton J. Towards individualised treatment in COPD. Thorax. 2011; 66: 363–364.
9. Han MeiLan K., Agusti A., Calverely P. et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182 (5): 598–604.
10. Parr D.G. Patient phenotyping and early disease detection in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc.2011; 8: 338–349.
11. Pistolesi M., Camiciottoli G., Paoletti M. et. al. Identification of a predominant COPD phenotype in clinical practice. Respir. Med. 2008; 102 (3): 367–376.
12. Weatherall M., Travers J., Shirtcliffe P.M. et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur. Respir. J. 2009; 34: 812–818.
13. Garcia-Aymerich J., Gomez F.P., Benet M. et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430–437.
14. Agusti A., Calverley P., Celli B. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11 (1): 122.
15. Hurst J.R., Vestbo J., Anzueto A. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128–1138.
16. Vestbo J., Anderson W., Coxson H.O. et al. Evaluation of COPD. Longitudinally to identify predictive surrogate endpoints (ECLIPSE). Eur. Respir. J. 2008; 31: 869–873.
17. Овчаренко С.И., Капустина В.А. Хроническая обструктивная болезнь легких: особенности у женщин. Пульмонология 2009; 2: 102–112.
18. Трофименко И.Н., Черняк Б.А. Бронхиальная гиперреактивность как фенотипическая характеристика хронической обструктивной болезни легких. Пульмонология 2011; 4: 49–53.
19. Barnes P. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009; 33: 1165–1185.
20. Hargreave F.E., Parameswaran K. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2006; 28 (2): 264–267.
21. Salazar L.M., Herrera A.M. Fibrotic response of tissue remodeling in COPD. Lung 2011; 189 (2): 101–109.
22. Невилл С.О. (ред.). Современное состояние учения о хроническом бронхите. М. 1963.
23. Давыдовский И.В. Общая патология человека. М.: Медицина; 1969.
24. Гастева З.А., Нешель Е.В., Успенская В.Г. Пневмофиброзы и эмфизема легких. Л.; 1965.
25. Гарбиньский Д.Т. Болезни системы дыхания. Варшава; 1967.
26. Attili A. K., Kazerooni E.A., Gross B.H. et al. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. RadioGraphics 2008; 28: 1383–1396.
27. Kosciuch J., Krenke R., Gorska K. et al. Relationship between airway wall thickness assessed by high-resolution computed tomography and lung function in patients with asthma and chronic obstructive pulmonary disease. J. Physiol. Pharmacol. 2009; 60: 71–76.
28. Marten K., Milne D., Antoniou K.M. et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur. Radiol. 2009; 19 (7): 1679–1685.
29. Wiggins J., Strickland B., Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir. Med. 1990; 84 (5): 365–369.
30. Fujimoto K., Kitaguchi Y., Kubo K., Honda T. Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography. Respirology 2006; 11 (6): 731–740.
31. Gauldie J., Kolb M., Ask K. et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc. Am. Thorac. Soc. 2006; 3 (8): 696–702.
32. Jankowich M.D., Polsky M., Klein M., Rounds S. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration 2008; 75 (4): 411–417.
33. Jankowich M. D., Rounds Sh.I.S. Combined pulmonary fibrosis and emphysema syndrome: a review. Chest 2012; 141 (1): 222–231.
34. Kitaguchi Y., Fujimoto K., Hanaoka M. et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15 (2): 265–271.
35. Todd N.W., Jeudy J., Lavania S. et al. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenes. Tissue Repair 2011; 4: 6.
36. Cottin V., Nunes H., Brillet P.Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26 (4): 586–593.
37. Cottin V., Cordier J.-F. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1211–1219.
38. Adesina A.M., Vallyathan V., McQuillen E.N. et al. Bronchiolar inflammation and fibrosis associated with smoking. A morphologic cross-sectional population analysis. Am. Rev. Respir. Dis. 1991; 143: 144–149.
39. Antoniou K.M., Hansell D.M., Rubens M.B. et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am. J. Respir. Crit. Care Med. 2008; 177 (2): 190–194.
40. Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41 (3): 316–325.
41. Baka Zs., Buzas E., Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthr. Res. Ther. 2009; 11 (4): 238.
42. Costenbader K.H., Feskanich D., Mandl L.A., Karlson E.W. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am. J. Med. 2006; 119: 503.e1–503.e9.
43. Klareskog L., Stolt P., Lundberg K. et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr. & Rheum. 2006; 54 (1): 38–46.
44. Balbi B., Cottin V., Singh S. et al. Smoking-related lung diseases: a clinical perspective. Clinical assembly contribution to the celebration of 20 years of the ERS. Eur. Respir. J. 2010; 35 (2): 231–233.
45. Galvin J.R., Teri F.J. Smoking-related lung disease. J. Thorac. Imag. 2009; 24 (4): 274–284.
46. Абросимов В.Н. и др. "Синие отечники" и "розовые с одышкой", а может быть еще и "синие с одышкой"? В кн.: Одышка и ассоциированные синдромы: Межрегиональный сборник науч. трудов. Рязань: ГБОУ ВПО РязГМУ Минздравсоцразвития России; 2012.
47. Авдеев С.Н. Определение клинических фенотипов хронической обструктивной болезни легких. Новый подход к терапии заболевания. Тер. арх. 2011; 3: 66–74.
Для цитирования:
Абросимов В.Н. Хроническая обструктивная болезнь легких и пневмосклероз – еще один фенотип. Пульмонология. 2012;(4):95-99. https://doi.org/10.18093/0869-0189-2012-0-4-95-99
For citation:
Abrosimov V.N. Chronic obstructive pulmonary disease and pulmonary sclerosis: is it one phenotype more?. Russian Pulmonology. 2012;(4):95-99. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-4-95-99
Просмотров: 398
Послать статью по эл. почте 